NCT04814498View on ClinicalTrials.gov

Drug-Drug Interaction (DDI) Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

September 17, 2021

Study Completion Date

January 11, 2022

Conditions

Drug Drug Interaction

Interventions

DRUG

Geneva Cocktail

Fixed sequence use of drug cocktail

DRUG

BLD-0409

Fixed sequence use of active product

Trial Locations (1)

4006

Nucleus Network Pty Ltd., Herston

Sponsors

Lead Sponsor

Blade Therapeutics

All Listed Sponsors

lead

Blade Therapeutics

INDUSTRY

NCT04814498 - Drug-Drug Interaction (DDI) Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter